Literature DB >> 6287806

Dose dependent induction of rat liver microsomal cytochrome P-450 and microsomal enzymatic activities after inhalation of toluene and dichloromethane.

R Toftgård, O G Nilsen, J A Gustafsson.   

Abstract

Sprague-Dawley rats were exposed, by inhalation, to toluene and dichloromethane (500, 1,500 or 3,000 p.p.m.) and to benzene (1,500 p.p.m.) for three days. Toluene and benzene increased the concentration of liver microsomal cytochrome P-450. A dose dependent increase in the in vitro liver microsomal formation of several metabolites of biphenyl and benzo(a)pyrene was observed for both dichloromethane and toluene. At the highest dose-level the increase in the vitro formation of benzo(a)pyrene-7,8-dihydrodiol was more than three-fold for both dichloromethane and toluene whereas the formation of benzo(a)pyrene-4,5-dihydrodiol increased more than five-fold following exposure to toluene but less than two-fold after exposure to dichloromethane. Our results suggest that dichloromethane and toluene can modify the metabolism and thereby the toxicity of other environmental contaminants.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6287806     DOI: 10.1111/j.1600-0773.1982.tb00999.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  4 in total

1.  Exposure to toluene increases the urinary excretion of D-glucaric acid.

Authors:  A Moretto; M Lotti
Journal:  Br J Ind Med       Date:  1990-01

2.  Subclinical effects of groundwater contaminants. III. Effects of repeated oral exposure to combinations of benzene and toluene on immunologic responses in mice.

Authors:  G C Hsieh; R D Parker; R P Sharma; B J Hughes
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

3.  The hepatotoxic potential of combined toluene-chronic ethanol exposure.

Authors:  S R Howell; J E Christian; G E Isom
Journal:  Arch Toxicol       Date:  1986-05       Impact factor: 5.153

4.  A physiological model for the pharmacokinetics of methylene chloride in B6C3F1 mice following i.v. administrations.

Authors:  M J Angelo; K B Bischoff; A B Pritchard; M A Presser
Journal:  J Pharmacokinet Biopharm       Date:  1984-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.